• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication.

作者信息

Ederhy Stephane, Dolladille Charles, Thuny Franck, Alexandre Joachim, Cohen Ariel

机构信息

Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Department of Cardiology, Paris, France; INSERM U 856, Paris, France and UNICO APHP.6 Cardio-oncology Program.

Department of Pharmacology, CHU Caen, PICARO Cardio-Oncology Programme, Caen, France.

出版信息

Eur J Heart Fail. 2019 Jul;21(7):945-947. doi: 10.1002/ejhf.1497.

DOI:10.1002/ejhf.1497
PMID:31353808
Abstract
摘要

相似文献

1
Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication.接受免疫检查点抑制剂治疗的癌症患者中的应激性心肌病：一种新的不良心脏并发症。
Eur J Heart Fail. 2019 Jul;21(7):945-947. doi: 10.1002/ejhf.1497.
2
Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors.接受免疫检查点抑制剂治疗的癌症患者中的类Takotsubo综合征
JACC Cardiovasc Imaging. 2018 Aug;11(8):1187-1190. doi: 10.1016/j.jcmg.2017.11.036. Epub 2018 Mar 14.
3
Cardiotoxicity associated with immune checkpoint inhibitors in cutaneous oncology.皮肤肿瘤学中与免疫检查点抑制剂相关的心脏毒性。
J Am Acad Dermatol. 2020 Apr;82(4):986-994. doi: 10.1016/j.jaad.2019.08.033. Epub 2019 Aug 19.
4
Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies.免疫检查点抑制剂癌症免疫疗法相关免疫介导反应的药物警戒评估。
Pharmacotherapy. 2017 Nov;37(11):1383-1390. doi: 10.1002/phar.2035. Epub 2017 Oct 26.
5
Thyroiditis and immune check point inhibitors: the post-marketing experience using the French National Pharmacovigilance database.甲状腺炎与免疫检查点抑制剂：利用法国国家药物警戒数据库的上市后经验
Fundam Clin Pharmacol. 2019 Apr;33(2):241-249. doi: 10.1111/fcp.12423. Epub 2018 Nov 14.
6
Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.转移性尿路上皮癌的免疫治疗：聚焦免疫检查点抑制。
Nat Rev Urol. 2018 Feb;15(2):112-124. doi: 10.1038/nrurol.2017.190. Epub 2017 Dec 5.
7
Management of immune-related adverse events resulting from immune checkpoint blockade.免疫检查点阻断相关免疫相关不良事件的管理。
Expert Rev Anticancer Ther. 2019 Mar;19(3):209-222. doi: 10.1080/14737140.2019.1562342. Epub 2019 Jan 9.
8
Immune checkpoint-associated cardiotoxicity: case report with systematic review of literature.免疫检查点相关心脏毒性：病例报告及文献系统综述
Ann Oncol. 2017 Aug 1;28(8):2034-2038. doi: 10.1093/annonc/mdx213.
9
Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis.免疫检查点抑制剂治疗实体瘤相关肺炎和间质性肺病的风险：系统评价和荟萃分析。
Front Immunol. 2019 Feb 4;10:108. doi: 10.3389/fimmu.2019.00108. eCollection 2019.
10
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors.癌症患者接受免疫检查点抑制剂治疗后的晚期心脏不良事件。
J Immunother Cancer. 2020 Jan;8(1). doi: 10.1136/jitc-2019-000261.

引用本文的文献

1
Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitors: Interpreting the Discrepancy Between Clinical Trials and Real-World Data.免疫检查点抑制剂相关的心血管毒性：解读临床试验与真实世界数据之间的差异
Cureus. 2025 Jun 30;17(6):e87049. doi: 10.7759/cureus.87049. eCollection 2025 Jun.
2
Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease.他汀类药物在减轻抗癌治疗相关心血管疾病中的作用。
Int J Mol Sci. 2024 Sep 22;25(18):10177. doi: 10.3390/ijms251810177.
3
Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes.
癌症患者心肌缺血的机制：阻塞性与非阻塞性病因的最新综述
Rev Cardiovasc Med. 2022 Jun 24;23(7):227. doi: 10.31083/j.rcm2307227. eCollection 2022 Jul.
4
Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure.心肌生理学和病理学中的免疫检查点：心力衰竭的治疗靶点。
Nat Rev Cardiol. 2024 Jul;21(7):443-462. doi: 10.1038/s41569-023-00986-9. Epub 2024 Jan 26.
5
A contemporary update on cancer and takotsubo syndrome.癌症与应激性心肌病的当代进展
Front Cardiovasc Med. 2024 Jan 8;10:1301383. doi: 10.3389/fcvm.2023.1301383. eCollection 2023.
6
Pembrolizumab-Induced Broken Heart Syndrome, Pneumonitis, and Hypophysitis Occurring Concurrently; A Deadly Triad.帕博利珠单抗诱发的心碎综合征、肺炎和垂体炎同时发生；致命三联征。
J Community Hosp Intern Med Perspect. 2023 May 8;13(3):88-90. doi: 10.55729/2000-9666.1173. eCollection 2023.
7
The Immunology of Takotsubo Syndrome.Takotsubo 综合征的免疫学。
Front Immunol. 2023 Oct 6;14:1254011. doi: 10.3389/fimmu.2023.1254011. eCollection 2023.
8
Role of echocardiography in patients treated with immune checkpoints inhibitors.超声心动图在免疫检查点抑制剂治疗患者中的作用。
J Echocardiogr. 2023 Dec;21(4):145-148. doi: 10.1007/s12574-023-00621-z. Epub 2023 Aug 30.
9
Immune Checkpoint Inhibitor-Related Stress Cardiomyopathy: Differential Diagnosis and Key Role of Cardiac Imaging.免疫检查点抑制剂相关应激性心肌病：鉴别诊断及心脏成像的关键作用
JACC Case Rep. 2023 Jun 21;16:101881. doi: 10.1016/j.jaccas.2023.101881.
10
Cardiovascular events after the initiation of immune checkpoint inhibitors.免疫检查点抑制剂开始使用后的心血管事件。
Heliyon. 2023 May 18;9(5):e16373. doi: 10.1016/j.heliyon.2023.e16373. eCollection 2023 May.